MannKind Corp. Company Profile (NASDAQ:MNKD)

About MannKind Corp.

MannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Biotechnology
Exchange: NASDAQ
Symbol: MNKD
CUSIP: 56400P20

Key Metrics:

Previous Close: $0.62
50 Day Moving Average: $0.795
200 Day Moving Average: $1.140
52-Week Range: $0.55 - $3.79
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -3.21
P/E Growth: -0.090
Market Cap: $304.04M
Outstanding Shares: 478,048,000
Beta: 1.69

Profitability:

Return on Assets: -66.16%

Debt:

Debt-to-Equity Ratio: -0.40%
Current Ratio: 0.31%
Quick Ratio: 0.30%

Additional Links:

Companies Related to MannKind Corp.:

Consensus Ratings for MannKind Corp. (NASDAQ:MNKD) (?)

Ratings Breakdown:	4 Sell Ratings, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:	Hold (Score: 1.71)
Consensus Price Target:	$2.79 (358.13% upside)

Analysts' Ratings History for MannKind Corp. (NASDAQ:MNKD)

Show:

Date	Firm	Action	Rating	Price Target
8/31/2016	S&P Equity Research	Lower Price Target		$0.84 -> $0.70
8/21/2016	Piper Jaffray Cos.	Set Price Target	Sell	$0.10
8/8/2016	JPMorgan Chase & Co.	Reiterated Rating	Sell
6/1/2016	Royal Bank Of Canada	Lower Price Target	Underperform	$1.00 -> $0.15
4/28/2016	JMP Securities	Reiterated Rating	Hold
4/1/2016	Goldman Sachs Group Inc.	Reiterated Rating	Sell
1/6/2016	Griffin Securities	Upgrade	Neutral -> Buy	$4.00
11/14/2015	Jefferies Group	Reiterated Rating	Buy	$9.00
5/11/2015	MLV & Co.	Lower Price Target	Hold	$7.00 -> $4.00

(Data available from 9/28/2014 forward)

Earnings History for MannKind Corp. (NASDAQ:MNKD)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Release Link	Conference Call
11/7/2016
8/8/2016	Q2	($0.06)	($0.07)	$0.03 million	View	N/A
5/9/2016	Q116	($0.04)	($0.06)		View	N/A
3/14/2016	Q4	($0.05)	($0.66)	$0.35 million	View	N/A
11/9/2015	Q315	($0.07)	($0.08)		View	N/A
8/10/2015	Q215	($0.08)	($0.07)	$0.53 million	View	Listen
5/7/2015	Q115	($0.08)	($0.08)		View	Listen
2/24/2015	Q414	($0.09)	($0.09)	$3.13 million	View	Listen
11/3/2014	Q314	$0.04	($0.09)	$66.60 million	View	Listen
8/11/2014	Q214	($0.12)	($0.19)		View	Listen
5/12/2014	Q114	($0.13)	($0.14)		View	Listen
2/18/2014	Q4	($0.14)	($0.16)	$0.43 million	View	Listen
11/4/2013	Q313	($0.14)	($0.17)		View	Listen
8/9/2013	Q2 2013	($0.14)	($0.16)		View	N/A
5/9/2013	Q1 2013	($0.15)	($0.15)		View	Listen
2/11/2013	Q4 2012	($0.19)	($0.23)		View	Listen
11/1/2012	Q312	($0.24)	($0.22)		View	N/A
8/7/2012		($0.24)	($0.23)		View	N/A
5/9/2012		($0.23)	($0.27)		View	N/A
2/22/2012		($0.32)	($0.30)		View	N/A
11/3/2011		($0.32)	($0.31)		View	N/A
8/4/2011		($0.30)	($0.37)		View	N/A
5/9/2011		($0.29)	($0.34)		View	N/A
2/10/2011		($0.40)	($0.33)		View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for MannKind Corp. (NASDAQ:MNKD)

Current Year EPS Consensus Estimate: $-0.230 EPS
Next Year EPS Consensus Estimate: $-0.190 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.03)	($0.03)	($0.03)
Q2 2016	1	($0.03)	($0.03)	($0.03)
Q3 2016	1	($0.03)	($0.03)	($0.03)
Q4 2016	1	($0.03)	($0.03)	($0.03)

(Data provided by Zacks Investment Research)

Dividend History for MannKind Corp. (NASDAQ:MNKD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for MannKind Corp. (NASDAQ:MNKD)

Insider Ownership Percentage: 0.94%
Institutional Ownership Percentage: 18.90%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/26/2016	Michael Castagna	Insider	Buy	17,500	$0.78	$13,650.00
8/24/2016	Michael Castagna	Insider	Buy	15,000	$0.87	$13,050.00
8/23/2016	Michael Castagna	Insider	Buy	25,000	$0.94	$23,500.00
8/15/2016	Matthew J Pfeffer	CEO	Buy	25,000	$0.99	$24,750.00
8/12/2016	Michael Castagna	Insider	Buy	25,000	$1.00	$25,000.00
5/17/2016	Michael Castagna	Insider	Buy	50,000	$0.93	$46,500.00
4/24/2015	Hakan Edstrom	CEO	Sell	73,460	$4.83	$354,811.80
3/27/2015	Hakan Edstrom	CEO	Sell	73,460	$5.21	$382,726.60
2/10/2015	Hakan Edstrom	CEO	Sell	73,460	$7.75	$569,315.00
2/5/2015	David Thomson	VP	Sell	80,000	$7.00	$560,000.00
1/5/2015	Diane Palumbo	VP	Sell	188,999	$5.95	$1,124,544.05
11/24/2014	David Thomson	VP	Sell	118,114	$6.14	$725,219.96
10/3/2014	Juergen Martens	VP	Sell	63,800	$5.48	$349,624.00
8/27/2014	Juergen Martens	VP	Sell	417	$7.60	$3,169.20
8/7/2014	David Thomson	VP	Sell	30,000	$8.16	$244,800.00
7/21/2014	Juergen Martens	VP	Sell	26,458	$9.65	$255,319.70
7/15/2014	Diane Palumbo	VP	Sell	17,901	$10.01	$179,189.01
7/1/2014	Matthew J Pfeffer	CFO	Sell	20,000	$10.44	$208,800.00
6/30/2014	Hakan Edstrom	COO	Buy	1,692	$4.42	$7,478.64
6/27/2014	Juergen Martens	VP	Sell	25,417	$10.53	$267,641.01
6/26/2014	David Thomson	VP	Sell	30,000	$10.51	$315,300.00
6/20/2014	Juergen Martens	VP	Sell	1,458	$10.34	$15,075.72
6/16/2014	Diane Palumbo	VP	Sell	17,902	$10.59	$189,582.18
6/5/2014	Juergen Martens	VP	Sell	120,000	$11.00	$1,320,000.00
6/4/2014	David Thomson	VP	Sell	133,000	$9.95	$1,323,350.00
6/3/2014	Diane Palumbo	VP	Sell	52,957	$9.50	$503,091.50
5/23/2014	Juergen Martens	VP	Sell	25,000	$7.65	$191,250.00
5/19/2014	Juergen Martens	VP	Sell	76,899	$7.50	$576,742.50
5/15/2014	Diane Palumbo	VP	Sell	18,176	$7.06	$128,322.56
1/24/2014	Juergen Martens	VP	Sell	50,000	$5.56	$278,000.00
12/31/2013	Hakan Edstrom	COO	Buy	1,589	$4.53	$7,198.17
12/20/2013	Juergen Martens	VP	Sell	32,054	$5.00	$160,270.00
12/11/2013	David Thomson	VP	Sell	150,000	$5.00	$750,000.00
11/29/2013	Juergen Martens	VP	Sell	48,057	$5.01	$240,765.57
11/15/2013	Diane Palumbo	VP	Sell	25,000	$5.02	$125,500.00
8/28/2013	David Thomson	VP	Sell	19,204	$5.78	$110,999.12
8/26/2013	Juergen Martens	VP	Sell	20,000	$5.52	$110,400.00
8/1/2013	Matthew J Pfeffer	CFO	Sell	10,000	$8.00	$80,000.00
7/2/2013	Matthew J Pfeffer	CFO	Sell	10,000	$7.00	$70,000.00
6/30/2013	Diane Palumbo	VP	Buy	1,610	$1.96	$3,155.60
6/30/2013	Matthew J Pfeffer	CFO	Buy	7,448	$1.96	$14,598.08
6/3/2013	Diane Palumbo	VP	Sell	66,849	$7.50	$501,367.50
5/16/2013	Diane Palumbo	VP	Sell	26,829	$5.25	$140,852.25
5/15/2013	Matthew J Pfeffer	CFO	Sell	10,000	$5.00	$50,000.00
12/31/2012	Matthew J Pfeffer	CFO	Buy	1,056	$1.95	$2,059.20
12/21/2012	Alfred E Mann	Major Shareholder	Buy	40,000,000	$2.59	$103,600,000.00

(Data available from 1/1/2013 forward)

Latest Headlines for MannKind Corp. (NASDAQ:MNKD)

Date	Headline
	Trading the Biotech News: MannKind Corp. (NASDAQ:MNKD), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 28 at 11:07 AM
	Can MannKind Compete Against Mylan's EpiPen? (MNKD) - Investopedia (NASDAQ:MNKD) www.investopedia.com - September 27 at 6:03 PM
	2 Biotech Stocks News And Price Trends: MannKind Corp. (NASDAQ:MNKD), Northwest Biotherapeutics, Inc ... - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 27 at 6:03 PM
	Top Biotechnology Stock Picking: Gilead Sciences Inc. (GILD), MannKind Corp. (MNKD) - The Independent Republic (NASDAQ:MNKD) theindependentrepublic.com - September 27 at 6:03 PM
	Top Biotechnology Stock Picking: Sarepta Therapeutics, Inc. (SRPT), MannKind Corp. (MNKD) - The Independent Republic (NASDAQ:MNKD) theindependentrepublic.com - September 27 at 6:03 PM
	Can MannKind Compete Against Mylan's EpiPen? (MNKD) (NASDAQ:MNKD) www.investopedia.com - September 26 at 6:11 PM
	MannKind Corporation (NASDAQ:MNKD) Delisting A Real Concern - The Oracle Dispatch (NASDAQ:MNKD) oracledispatch.com - September 25 at 5:32 PM
	MannKind (MNKD) Receives Notice of Delisting (NASDAQ:MNKD) www.streetinsider.com - September 23 at 5:48 PM
	MannKind's Delisting Notice: Key Takeaways (NASDAQ:MNKD) seekingalpha.com - September 23 at 5:48 PM
	MannKind (MNKD) Stock: Falling Hard On Delisting Notice (NASDAQ:MNKD) cnafinance.com - September 23 at 5:48 PM
	Keen Investors Find News on MannKind Corp. (NASDAQ:MNKD) - Duncan Research (NASDAQ:MNKD) www.duncanindependent.com - September 23 at 10:53 AM
	MannKind's Delisting Notice: Key Takeaways - Seeking Alpha (NASDAQ:MNKD) seekingalpha.com - September 23 at 10:53 AM
	News review of 2 biotech stocks: MannKind Corp. (NASDAQ:MNKD), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 23 at 10:53 AM
	News review of 2 biotech stocks: MannKind (NASDAQ:MNKD), PTC Therapeutics (NASDAQ:PTCT) - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 22 at 5:55 PM
	Under the Microscope, Zeroing in at MannKind Corp. (NASDAQ:MNKD) - Duncan Research (NASDAQ:MNKD) www.duncanindependent.com - September 22 at 5:55 PM
	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra (NASDAQ:MNKD) biz.yahoo.com - September 22 at 10:59 AM
	MANNKIND CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:MNKD) www.4-traders.com - September 22 at 10:59 AM
	MANNKIND CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra (NASDAQ:MNKD) biz.yahoo.com - September 22 at 10:59 AM
	Penny Stock Investors Keen on Shares of MannKind Corp. (NASDAQ:MNKD) - Duncan Research (NASDAQ:MNKD) www.duncanindependent.com - September 21 at 5:52 PM
	Active Biotech Stock News: MannKind Corp. (MNKD), Alexion Pharmaceuticals, Inc. (ALXN) - The Independent Republic (NASDAQ:MNKD) theindependentrepublic.com - September 21 at 5:52 PM
	News review of 2 biotech stocks: MannKind Corp. (NASDAQ:MNKD ... - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 21 at 5:52 PM
	CIALIS WITHOUT A DOCTORS PRESCRIPTION - Online Cialis No Prescription (NASDAQ:MNKD) richseo.in - September 21 at 10:19 AM
	Stock to Watch: MannKind Corp (MNKD), Amyris (AMRS) - Newburgh Press (NASDAQ:MNKD) newburghpress.com - September 20 at 11:22 AM
	Hot Biotech Stocks Recap: Celgene Corporation (NASDAQ:CELG ... - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 16 at 5:59 PM
	Two Biotechnology Names Are Hot: MannKind Corp. (MNKD), Celgene Corporation (CELG) - The Independent Republic (NASDAQ:MNKD) theindependentrepublic.com - September 16 at 8:59 AM
	HC Stocks to Path=! MannKind Corporation (MNKD), Zoetis Inc (NYSE:ZTS) - share market updates (press release) (NASDAQ:MNKD) sharemarketupdates.com - September 16 at 8:59 AM
	MNKD: How MannKind's Stock Price Fell 28% in 6 Months (NASDAQ:MNKD) www.investopedia.com - September 15 at 4:12 PM
	MannKind Corp. :MNKD-US: Earnings Analysis: Q2, 2016 By the Numbers : September 14, 2016 (NASDAQ:MNKD) www.capitalcube.com - September 14 at 6:17 PM
	New Market Report: MannKind Corporation (MNKD) - Medical Equipment - Deals and Alliances Profile (NASDAQ:MNKD) reports.pr-inside.com - September 13 at 11:01 AM
	MannKind Stock: 3 Things to Watch (MNKD) (NASDAQ:MNKD) www.investopedia.com - September 13 at 11:01 AM
	Top Biotechnology Stock Picking: MannKind Corp. (MNKD), Inovio Pharmaceuticals, Inc. (INO) - The Independent Republic (NASDAQ:MNKD) theindependentrepublic.com - September 12 at 5:57 PM
	Stocks Buzz: NetApp, Inc. (NTAP) MannKind Corp. (MNKD) Superior Energy Services, Inc. (SPN) - iStreetWire (NASDAQ:MNKD) istreetwire.com - September 12 at 5:57 PM
	Why MannKind Corp. Stock Fell 19.1% in August - Motley Fool (NASDAQ:MNKD) www.fool.com - September 9 at 5:55 PM
	Why MannKind Corp. Stock Fell 19.1% in August (NASDAQ:MNKD) www.fool.com - September 9 at 12:07 PM
	MannKind Corporation (MNKD) Stock: It’s Not Dead Yet! (NASDAQ:MNKD) cnafinance.com - September 9 at 10:53 AM
	MannKind Corporation (MNKD) Stock: It's Not Dead Yet! - CNA Finance (press release) (NASDAQ:MNKD) cnafinance.com - September 8 at 5:58 PM
	News review of 2 biotech stocks: Medivation, Inc. (NASDAQ:MDVN ... - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 8 at 10:01 AM
	MannKind Corporation (MNKD) Working to Take on Mylan’s EpiPen (NASDAQ:MNKD) investorplace.com - September 6 at 3:33 PM
	Valencia company developing inhaler alternative to EpiPen (NASDAQ:MNKD) www.bizjournals.com - September 6 at 10:54 AM
	MannKind Corporation (MNKD) Rumored to Seek Partners for EpiPen Development - TCC (NASDAQ:MNKD) www.thecountrycaller.com - September 5 at 5:34 PM
	MannKind Corporation (MNKD) Rumored to Seek Partners for EpiPen Development (NASDAQ:MNKD) www.thecountrycaller.com - September 5 at 10:29 AM
	5 Red Flags on MannKind's Balance Sheet (NASDAQ:MNKD) www.fool.com - September 4 at 3:30 PM
	MannKind Corporation to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:MNKD) finance.yahoo.com - September 2 at 6:10 PM
	Biotech news that matter for investors: MannKind Corp. (NASDAQ:MNKD), Array BioPharma Inc. (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:MNKD) voiceregistrar.com - September 2 at 11:01 AM
	MannKind: EpiPen To The Rescue (NASDAQ:MNKD) seekingalpha.com - September 1 at 6:04 PM
	Here's Why MannKind Just Soared 15% (And Why You Shouldn't Buy the Hype) (NASDAQ:MNKD) www.fool.com - September 1 at 2:16 AM
	MannKind says EpiPen alternative is lead program; shares up 13% (NASDAQ:MNKD) seekingalpha.com - August 31 at 12:38 PM
	MannKind - Afrezza Scripts, Class Actions Suits, Nasdaq Listing, Insider Buys, Insurance Woes - What Investors Need To Keep In Mind (NASDAQ:MNKD) seekingalpha.com - August 30 at 6:11 PM
	MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says (NASDAQ:MNKD) feeds.benzinga.com - August 30 at 5:40 PM
	Better Buy: Organovo Holdings, Inc. vs MannKind Corp. (NASDAQ:MNKD) www.fool.com - August 30 at 5:00 PM